RYAN ARTHUR F
In the last 12 months, RYAN ARTHUR F filed 50 SEC Form 4 transactions across 1 issuer: $0 in open-market purchases and $434.7K in open-market sales. 44% of these transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $434.7KOpen-market sells (1y)
- 50Transactions filed
- 1Distinct issuers
- 44%Under Rule 10b5-1
- 2026-07-02Latest filing
Issuers Filed For By open-market buy volume
Recent Form 4 Filings Most recent 50 of 50 (1-year window)
| Date | Ticker | Company | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $130.0K | 200 | $650.1 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $3.5K | 5 | $701.8 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $10.5K | 15 | $702.5 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $16.9K | 24 | $703.5 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $10.6K | 15 | $704.3 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $9.9K | 14 | $705.6 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $4.9K | 7 | $706.7 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $2.8K | 4 | $707.4 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $4.3K | 6 | $709.5 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $1.4K | 2 | $710.9 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $3.6K | 5 | $711.5 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $712 | 1 | $712.1 |
| 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $1.4K | 2 | $714.1 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $771 | 1 | $771.3 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $2.3K | 3 | $772.8 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $6.2K | 8 | $773.6 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $6.2K | 8 | $774.6 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $10.9K | 14 | $775.6 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $10.1K | 13 | $776.6 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $7.0K | 9 | $777.4 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $3.1K | 4 | $778.2 |
| 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell 10b5-1 | S | $31.2K | 40 | $779.7 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $5.4K | 7 | $777.5 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $1.6K | 2 | $778.3 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $3.9K | 5 | $779.7 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $2.3K | 3 | $780.7 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $1.6K | 2 | $781.2 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $1.6K | 2 | $782.6 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $7.8K | 10 | $783.6 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $7.1K | 9 | $784.5 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $8.6K | 11 | $785.5 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $5.5K | 7 | $786.6 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $1.6K | 2 | $787.3 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $15.8K | 20 | $789.0 |
| 2026-03-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $15.8K | 20 | $789.3 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $776 | 1 | $775.6 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $7.8K | 10 | $776.6 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $44.3K | 57 | $777.6 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $9.3K | 12 | $778.5 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $3.9K | 5 | $779.4 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $780 | 1 | $780.1 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $3.9K | 5 | $781.5 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $783 | 1 | $782.5 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $2.4K | 3 | $783.3 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $785 | 1 | $784.6 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $786 | 1 | $785.7 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $1.6K | 2 | $786.3 |
| 2026-02-09 | REGN | REGENERON PHARMACEUTICALS, INC. | Sell | – | $788 | 1 | $787.8 |
| 2026-01-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Grant | – | $0 | 155 | $0.0 |
| 2026-01-02 | REGN | REGENERON PHARMACEUTICALS, INC. | Grant | – | $0 | 1,962 | $0.0 |
Methodology & FAQ
How These Filings Are Sourced
All transactions on this page are sourced directly from SEC EDGAR. A complete description of the open-market vs grant distinction, the Rule 10b5-1 plan-reference heuristic, and the per-insider name matching is documented in the Methodology.
What companies does RYAN ARTHUR F file Form 4 disclosures for?
RYAN ARTHUR F has filed SEC Form 4 transactions for 1 issuer in the last 12 months: REGENERON PHARMACEUTICALS, INC. (REGN).
What does the 10b5-1 badge mean on these transactions?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Of RYAN ARTHUR F's 50 reported transactions in the last 12 months, 22 (44%) reference a 10b5-1 trading plan in the Form 4 footnotes.
Are these all the transactions RYAN ARTHUR F has executed?
This page shows SEC Form 4 transactions on record in Pactolio's tracked universe for the last 12 months. Form 4 only covers transactions in registered classes of equity at issuers where the person qualifies as an insider (officer, director, or 10% beneficial owner). Trades in funds, foreign issuers, or non-insider positions are not disclosed under Form 4 and are not included here.